BRISTOL-MYERS SQUIBB CO (1BMY.MI) Fundamental Analysis & Valuation
BIT:1BMY • US1101221083
Current stock price
52.8 EUR
-0.64 (-1.2%)
Last:
This 1BMY.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. 1BMY.MI Profitability Analysis
1.1 Basic Checks
- 1BMY had positive earnings in the past year.
- In the past year 1BMY had a positive cash flow from operations.
- Of the past 5 years 1BMY 4 years were profitable.
- In the past 5 years 1BMY always reported a positive cash flow from operatings.
1.2 Ratios
- 1BMY has a Return On Assets (7.83%) which is comparable to the rest of the industry.
- With an excellent Return On Equity value of 38.19%, 1BMY belongs to the best of the industry, outperforming 87.04% of the companies in the same industry.
- 1BMY has a better Return On Invested Capital (19.52%) than 77.78% of its industry peers.
- 1BMY had an Average Return On Invested Capital over the past 3 years of 14.47%. This is in line with the industry average of 14.90%.
- The 3 year average ROIC (14.47%) for 1BMY is below the current ROIC(19.52%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- Looking at the Profit Margin, with a value of 14.64%, 1BMY is in line with its industry, outperforming 57.41% of the companies in the same industry.
- 1BMY's Profit Margin has improved in the last couple of years.
- 1BMY has a better Operating Margin (35.82%) than 85.19% of its industry peers.
- 1BMY's Operating Margin has improved in the last couple of years.
- 1BMY has a Gross Margin (72.63%) which is comparable to the rest of the industry.
- 1BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. 1BMY.MI Health Analysis
2.1 Basic Checks
- 1BMY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for 1BMY has been increased compared to 1 year ago.
- Compared to 5 years ago, 1BMY has less shares outstanding
- 1BMY has a better debt/assets ratio than last year.
2.2 Solvency
- 1BMY has an Altman-Z score of 2.55. This is not the best score and indicates that 1BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 2.55, 1BMY perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
- 1BMY has a debt to FCF ratio of 3.51. This is a good value and a sign of high solvency as 1BMY would need 3.51 years to pay back of all of its debts.
- 1BMY has a better Debt to FCF ratio (3.51) than 64.81% of its industry peers.
- 1BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
- 1BMY has a worse Debt to Equity ratio (2.33) than 81.48% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.55 |
ROIC/WACC2.21
WACC8.82%
2.3 Liquidity
- 1BMY has a Current Ratio of 1.26. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- 1BMY has a Current ratio (1.26) which is comparable to the rest of the industry.
- 1BMY has a Quick Ratio of 1.14. This is a normal value and indicates that 1BMY is financially healthy and should not expect problems in meeting its short term obligations.
- 1BMY has a better Quick ratio (1.14) than 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. 1BMY.MI Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- Measured over the past years, 1BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
- 1BMY shows a decrease in Revenue. In the last year, the revenue decreased by -0.22%.
- The Revenue has been growing slightly by 2.54% on average over the past years.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- The Earnings Per Share is expected to decrease by -4.54% on average over the next years.
- The Revenue is expected to decrease by -5.62% on average over the next years.
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. 1BMY.MI Valuation Analysis
4.1 Price/Earnings Ratio
- 1BMY is valuated reasonably with a Price/Earnings ratio of 9.91.
- Compared to the rest of the industry, the Price/Earnings ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 83.33% of the companies listed in the same industry.
- 1BMY's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 25.96.
- 1BMY is valuated reasonably with a Price/Forward Earnings ratio of 10.02.
- Based on the Price/Forward Earnings ratio, 1BMY is valued cheaper than 83.33% of the companies in the same industry.
- 1BMY is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.04, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.91 | ||
| Fwd PE | 10.02 |
4.2 Price Multiples
- 1BMY's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. 1BMY is cheaper than 83.33% of the companies in the same industry.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of 1BMY indicates a rather cheap valuation: 1BMY is cheaper than 90.74% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.66 | ||
| EV/EBITDA | 7.42 |
4.3 Compensation for Growth
- The decent profitability rating of 1BMY may justify a higher PE ratio.
- 1BMY's earnings are expected to decrease with -3.16% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
5. 1BMY.MI Dividend Analysis
5.1 Amount
- 1BMY has a Yearly Dividend Yield of 4.27%, which is a nice return.
- 1BMY's Dividend Yield is rather good when compared to the industry average which is at 1.92. 1BMY pays more dividend than 81.48% of the companies in the same industry.
- 1BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.91.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
5.2 History
- The dividend of 1BMY is nicely growing with an annual growth rate of 6.51%!
Dividend Growth(5Y)6.51%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 71.52% of the earnings are spent on dividend by 1BMY. This is not a sustainable payout ratio.
- 1BMY's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
1BMY.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:1BMY (3/5/2026, 7:00:00 PM)
52.8
-0.64 (-1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.3%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap107.53B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target52.72 (-0.15%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
Yearly Dividend2.19
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)8.14%
PT rev (3m)16.41%
EPS NQ rev (1m)1.09%
EPS NQ rev (3m)-4.14%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.15%
Revenue NQ rev (1m)3.32%
Revenue NQ rev (3m)2.22%
Revenue NY rev (1m)6.63%
Revenue NY rev (3m)6.92%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.91 | ||
| Fwd PE | 10.02 | ||
| P/S | 2.58 | ||
| P/FCF | 9.66 | ||
| P/OCF | 8.77 | ||
| P/B | 6.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.42 |
EPS(TTM)5.33
EY10.09%
EPS(NY)5.27
Fwd EY9.98%
FCF(TTM)5.46
FCFY10.35%
OCF(TTM)6.02
OCFY11.41%
SpS20.5
BVpS7.86
TBVpS-9.52
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.7
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.55 |
F-Score7
WACC8.82%
ROIC/WACC2.21
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y-1.05%
EPS Next 2Y-1.88%
EPS Next 3Y-3.16%
EPS Next 5Y-4.54%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.88%
Revenue Next 2Y-2.07%
Revenue Next 3Y-5.43%
Revenue Next 5Y-5.62%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.75%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.78%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / 1BMY.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a fundamental rating of 5 / 10 to 1BMY.MI.
Can you provide the valuation status for BRISTOL-MYERS SQUIBB CO?
ChartMill assigns a valuation rating of 7 / 10 to BRISTOL-MYERS SQUIBB CO (1BMY.MI). This can be considered as Undervalued.
Can you provide the profitability details for BRISTOL-MYERS SQUIBB CO?
BRISTOL-MYERS SQUIBB CO (1BMY.MI) has a profitability rating of 7 / 10.
Can you provide the financial health for 1BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 5 / 10.
Is the dividend of BRISTOL-MYERS SQUIBB CO sustainable?
The dividend rating of BRISTOL-MYERS SQUIBB CO (1BMY.MI) is 7 / 10 and the dividend payout ratio is 71.52%.